Subject disposition for complete eye exam and TAE exam—all participants (n=389)
| Complete eye exam | ||||
|---|---|---|---|---|
| TAE exam | Absent | Present | Agreement (%) | κ |
| Visual acuity ≤0.5 | ||||
| Absent | 345 | 1 | 92 | 0.42 |
| Present or ungradable | 30 | 13 | ||
| Cataract | ||||
| Absent | 338 | 0 | 90 | 0.40 |
| Present or ungradable | 37 | 14 | ||
| DR ≥ moderate NPDR | ||||
| Absent | 298 | 3 | 80 | 0.21 |
| Present or ungradable | 74 | 14 | ||
| Any diabetic macular oedema | ||||
| Absent | 302 | 2 | 79 | 0.09 |
| Present or ungradable | 79 | 6 | ||
| Glaucoma or suspicion of | ||||
| Absent | 267 | 13 | 85 | 0.60 |
| Present or ungradable | 44 | 65 | ||
| AMD | ||||
| Absent | 299 | 3 | 79 | 0.15 |
| Present or ungradable | 77 | 10 | ||
| Concomitant ocular diseases | ||||
| Absent | 249 | 22 | 73 | 0.24 |
| Present or ungradable | 84 | 34 | ||
| Overall referable findings | ||||
| Absent | 169 | 14 | 77 | 0.55 |
| Present or ungradable | 75 | 131 | ||
AMD, age-related macular degeneration; DR, diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; TAE, technology-assisted eye.